Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhimin Shao

Showing results (111-120 of 203) with videos related to

Pageof 21
Sort By:
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|April 30, 2013
Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancerEinar Gudlaugsson, Jan Klos, Ivar Skaland, et al.
Cancer|July 26, 2020
A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastasesRong Guo, Yonghui Su, Jing Si, et al.
Breast Cancer Research and Treatment|October 4, 2016
The association between China's Great famine and risk of breast cancer according to hormone receptor status: a hospital-based studyAliya Alimujiang, Miao Mo, Ying Liu, et al.
Journal of Oncology|April 25, 2019
Characteristics of Mammographic Breast Density and Associated Factors for Chinese Women: Results from an Automated MeasurementTong Li, Lichen Tang, Ziba Gandomkar, et al.
Gland Surgery|February 26, 2021
The clinicopathological and MRI features of patients with BRCA1/2 mutations in familial breast cancerChao You, Qin Xiao, Xinyi Zhu, et al.
International Journal of Cancer|May 15, 2014
Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancerJian Zhang, Zhonghua Wang, Xichun Hu, et al.
Integrative Cancer Therapies|November 26, 2010
External qigong therapy for women with breast cancer prior to surgeryLorenzo Cohen, Zhen Chen, Banu Arun, et al.
Plos One|July 19, 2016
Quality of Life and Psychological State in Chinese Breast Cancer Patients Who Received BRCA1/2 Genetic TestingJiajia Qiu, Jiaqin Guan, Xiaochen Yang, et al.
Asia-Pacific Journal of Clinical Oncology|October 20, 2020
Postoperative radiotherapy improves overall survival in patients with primary squamous cell carcinoma of the breastXuanyi Wang, Li Zhang, Jurui Luo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 15, 2019
Current practice and barriers of mesh-assisted implant-based breast reconstruction in China: A nationwide cross-sectional survey of 110 hospitalsRong Guo, Lun Li, Yonghui Su, et al.
Pageof 21

Showing results (111-120 of 203) with videos related to

Sort By:
Pageof 21
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|April 30, 2013
Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancerEinar Gudlaugsson, Jan Klos, Ivar Skaland, et al.
Cancer|July 26, 2020
A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastasesRong Guo, Yonghui Su, Jing Si, et al.
Breast Cancer Research and Treatment|October 4, 2016
The association between China's Great famine and risk of breast cancer according to hormone receptor status: a hospital-based studyAliya Alimujiang, Miao Mo, Ying Liu, et al.
Journal of Oncology|April 25, 2019
Characteristics of Mammographic Breast Density and Associated Factors for Chinese Women: Results from an Automated MeasurementTong Li, Lichen Tang, Ziba Gandomkar, et al.
Gland Surgery|February 26, 2021
The clinicopathological and MRI features of patients with BRCA1/2 mutations in familial breast cancerChao You, Qin Xiao, Xinyi Zhu, et al.
International Journal of Cancer|May 15, 2014
Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancerJian Zhang, Zhonghua Wang, Xichun Hu, et al.
Integrative Cancer Therapies|November 26, 2010
External qigong therapy for women with breast cancer prior to surgeryLorenzo Cohen, Zhen Chen, Banu Arun, et al.
Plos One|July 19, 2016
Quality of Life and Psychological State in Chinese Breast Cancer Patients Who Received BRCA1/2 Genetic TestingJiajia Qiu, Jiaqin Guan, Xiaochen Yang, et al.
Asia-Pacific Journal of Clinical Oncology|October 20, 2020
Postoperative radiotherapy improves overall survival in patients with primary squamous cell carcinoma of the breastXuanyi Wang, Li Zhang, Jurui Luo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 15, 2019
Current practice and barriers of mesh-assisted implant-based breast reconstruction in China: A nationwide cross-sectional survey of 110 hospitalsRong Guo, Lun Li, Yonghui Su, et al.
Pageof 21